Related Experiment Video
Updated: Jul 14, 2026
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
beta-Agonist enhances type 2 T-cell survival and accumulation
Matthew J Loza1, Stephen P Peters, Susan Foster
1Department of Internal Medicine, Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
The Journal of Allergy and Clinical Immunology
|January 9, 2007
Summary
Beta-adrenergic agonists, unlike PGE(2), promote type 2 T cell accumulation by modulating cyclic AMP-dependent protein kinase (PKA) activity. This highlights their potential to influence T cell development and disease pathogenesis.
Area of Science:
- Immunology
- Molecular Pharmacology
- Cell Biology
Background:
- Neurohumoral modulation of immune function is not well understood.
- Beta-adrenergic agonists (beta-agonists) impact physiological processes and inflammatory diseases.
- Their role in immune cell modulation warrants further investigation.
Purpose of the Study:
- To determine the effects of beta-agonists and prostaglandin E(2) (PGE(2)) on T cell accumulation.
- To investigate the impact on type 1 (IFN-gamma(+)) and type 2 (IL-13(+)) T cells.
- To elucidate the underlying mechanisms involving G protein-coupled receptor agonists.
Main Methods:
- Assessed T-cell subtype accumulation in human peripheral blood lymphocytes using flow cytometry.
- Utilized alphaCD3/CD28 or IL-2 stimulation for T cell cultures.
- Investigated the role of cyclic AMP-dependent protein kinase (PKA) via substrate phosphorylation and patient-derived cells with PKA defects.
Main Results:
- Beta-agonists, but not PGE(2), increased IL-2-induced accumulation of type 2 T cells.
- This effect was linked to differential PKA activation influencing T cell proliferation and apoptosis.
- In patients with defective PKA activation, both agonists increased type 2 T cell accumulation.
Conclusions:
- G(s)-coupled receptors can induce prosurvival signaling in type 2 T cells.
- This effect is often masked by simultaneous antimitogenic PKA activation.
- Beta-agonists and related agonists can regulate T cell development, impacting disease and therapy, with effects varying based on PKA stimulation capacity.
More Related Videos
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...